Clinical Trial Update: Clarithromycin Resistant Tailored Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial results update on clarithromycin-resistant tailored therapy for Helicobacter pylori infection in peptic ulcer disease; results were posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Jin Il Kim | Conditions: Peptic Ulcer, Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED | Results posted: 2013-09-27